Cargando…
Effect of tofacitinib on cardiovascular events and all-cause mortality in patients with immune-mediated inflammatory diseases: a systematic review and meta-analysis of randomized controlled trials
BACKGROUND: We aimed to systematically assess a possible association of tofacitinib therapy with cardiovascular events (CVEs) and all-cause mortality. METHODS: Systematic searches of PubMed, Embase, and Cochrane Library were conducted from inception through March 2019. Randomized controlled trials i...
Autores principales: | Xie, Wenhui, Xiao, Shiyu, Huang, Yanrong, Sun, Xiaoying, Zhang, Zhuoli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918042/ https://www.ncbi.nlm.nih.gov/pubmed/31897092 http://dx.doi.org/10.1177/1759720X19895492 |
Ejemplares similares
-
Meta-Analysis of Self-Reported Daytime Napping and Risk of Cardiovascular or All-Cause Mortality
por: Liu, Xiaokun, et al.
Publicado: (2015) -
Milk and dairy consumption and risk of cardiovascular diseases and all-cause mortality: dose–response meta-analysis of prospective cohort studies
por: Guo, Jing, et al.
Publicado: (2017) -
The Effect of Endogenous Cushing Syndrome on All-cause and Cause-specific Mortality
por: Limumpornpetch, Padiporn, et al.
Publicado: (2022) -
Sedentary behaviour and risk of all-cause, cardiovascular and cancer mortality, and incident type 2 diabetes: a systematic review and dose response meta-analysis
por: Patterson, Richard, et al.
Publicado: (2018) -
Real-world experience with tofacitinib in ulcerative colitis: a systematic review and meta-analysis
por: Lucaciu, Laura A., et al.
Publicado: (2021)